Background: Cryptogenic stroke accounts for 30% to 40% of ischemic stroke. It is essential
to determine the possible culprit because this will improve secondary stroke prevention …

Stroke occurs across the lifespan with unique issues in the fetus, neonate, and child. The
past decade has seen substantial advances in paediatric stroke research and clinical care …

Cryptogenic (of unknown cause) ischaemic strokes are now thought to comprise about 25%
of all ischaemic strokes. Advances in imaging techniques and improved understanding of …

Objectives This article provides recommendations on the use of antithrombotic therapy in
patients with stroke or transient ischemic attack (TIA). Methods We generated treatment …

Rationale Cryptogenic ischemic strokes constitute 20–30% of ischemic strokes, the majority
of which are embolic strokes of undetermined source. The standard preventive treatment in …

BACKGROUND: Posterior fossa strokes, particularly those related to basilar occlusion, pose
a high risk for progression and poor neurological outcomes. The clinical history and …

Background: Predicting aphasia recovery after stroke has been difficult due to substantial
variability in outcomes. Few studies have characterised the nature and extent of recovery …

Background For childhood-onset arterial ischaemic stroke (AIS), treatment trials are lacking
and practices vary from country to country and centre to centre. We aimed to describe …

Background Embolic strokes of undetermined source comprise up to 20% of ischemic
strokes. The stroke recurrence rate is substantial with aspirin, widely used for secondary …

Objective: The cause of stroke remains unknown or cryptogenic in many patients. We sought
to determine whether gene expression signatures in blood can distinguish between …